District Court, D. Delaware December 13, 2023, 1:20-cv-00985 (ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited)
Also known as
United States · · · 13-12-2023
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
ACADIA PHARAMCEUTICALS INC.,
Plaintiff,
C.A. No. 20-985-GBW
v.
AUROBINDO PHARMA LIMITED et ai., CONSOLIDATED
Defendants.
MEMORANDUM ORDER .
Defendants MSN Laboratories PVT. Ltd. and MSN Pharmaceuticals, Inc. (collectively,
“MSN”) filed an Abbreviated New Drug Application (“ANDA”) for a generic version of the
Parkinson’s drug Nuplazid®. The FDA tentatively approved MSN’s ANDA. Acadia
Pharmaceuticals, Inc. (“Acadia”) asserted five patents against MSN but has voluntarily dismissed
or stipulated to non-infringement of four of them. D.I. 144, 176. Acadia also has resolved its
disputes with all other defendants, either by stipulating to dismissal or reaching an agreement to
be bound by the outcome of the present case. D.I. 87; D.I. 236; D.I. 253; D.I. 254. The parties
have reached an agreement to limit the dispute to just the invalidity of claim 26 of U.S. Patent No.
7,601,740 (“the ‘740 patent”) and have stipulated to a set of undisputed facts to support a summary
judgment on this issue. D.I. 256, D.I. 257, D.I. 258. The Court heard oral argument on the parties’
cross-motions for summary judgment on September 26, 2023. Transcript. (“Tr.”). For the reasons
given below, the Court denies MSN’s motion for summary judgment and grants Acadia’s cross-
motion for summary judgment.!
1 MSN argues that Acadia has not properly requested leave to file a cross-motion. D.I. 263 at 1.
Because the parties stipulated to resolution of the case on summary judgment, D.I. 256, the Court
holds that Acadia’s cross-motion is proper.
I. BACKGROUND
The facts are not in dispute for this motion. D.I. 158 (“Joint Statement of Undisputed
Facts”).2 MSN challenges the ’740 patent based on U.S. Patent No. 9,566,271 (‘the 271 patent”).
The challenged °740 patent traces back to U.S. Patent Application No. 10/759,561 (“the °561
application”), which was filed on January 15, 2004. JSUF 7 16. The reference ’271 patent traces
back to U.S.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit